To evaluate the outcome of local resection versus combined local resection and plaque radiotherapy in the treatment of choroidal melanoma.
Methods
We retrospectively analyzed the records of 60 patients (60 eyes) managed by local resection (group 1, 30 patients, external or internal local resection) or combined local resection and plaque radiotherapy (group 2, 30 patients, both Ruthenium-106 or Cobalt-60), among the 364 melanomas treated at our Department of Ophthalmology, between January 1980 and December 2006. Main outcomes measures were postsurgical complications, visual acuity, local recurrence, reasons for enucleation, and development of metastasis.
Results
The 2 groups of patients were considered sufficiently homogeneous as regards location, cell type, and age. Mean follow-up was 7 years. The median largest basal tumor diameter was 9.8 mm and 10.1, and the median tumor thickness was 7.9 mm and 8, respectively, in groups 1 and 2. No statistically significant differences resulted between group 1 and group 2 as regards postsurgical complications (vitreous hemorrhage, retinal detachment, maculopathy cataract, and optic neuropathy) (p>0.05), visual acuity (p>0.05), local recurrence (p>0.05), reasons for enucleation (p>0.05), or development of metastasis (p>0.05).
Conclusions
NO adjunctive benefits from the combined local resection and plaque radiotherapy can be ruled out from our study.
The Collaborative Ocular Melanoma Study Group.The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol2001; 119: 969–82.
3.
LeyvrazS., SpataroV., BauerJ.. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol1997; 15: 2589–95.
4.
The Collaborative Ocular Melanoma Study Group.Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report No. 15. Arch Ophthalmol2001; 119: 670–6.
5.
DamatoB., LecuonaK.Conservation of eyes with choroidal melanoma by a multimodality approach to treatment. An audit of 1632 patients. Ophthalmology2004; 111: 977–83.
6.
The Collaborative Ocular Melanoma Study Group.The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma II: characteristics of patients enrolled and not enrolled. COMS Report No. 17. Arch Ophthalmol2001; 119: 951–65.
7.
MargoC.E.The Collaborative Ocular Melanoma Study: an overview. Cancer Control2004; 11: 304–9.
8.
ZimmermanL.E., McLeanI.W., FosterW.D.Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells?Br J Ophthalmol1978; 62: 420–5.
9.
ShieldsC.L., ShieldsJ.A.Recent developments in the management of choroidal melanoma. Curr Opin Ophthalmol2004; 15: 244–51.
10.
ManschotW.A., van PeperzeelH.A.Choroidal melanoma. Enucleation or observation? A new approach. Arch Ophthalmol1980; 98: 71–7.
11.
SeigelD., MyersM., FerrisF3rd, SteinhomS.C.Survival rates after enucleation of eyes with malignant melanoma. Am J Ophthalmol1979, 87: 761–5.
12.
LommatzschP.K., WerschnikC., SchusterE.Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol2000; 238: 129–37.
13.
JampolL.M., MoyC.S., MurrayT.G.. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology2002; 109: 2197–206.
14.
GragoudasE., LiW., GoiteinM., LaneA.M., MunzenriderJ.E., EganK.M.Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol2002; 120: 1665–71.
15.
MuellerA.J., TaliesS., SchallerU.C., HorstmannG., WowraB., KampikA.Stereotactic radiosurgery of large uveal melanomas with the gamma-knife. Ophthalmology2000; 107: 1387–8.
16.
FouldsW.S., DamatoB.E.Low-energy long-exposure laser therapy in the management of choroidal melanoma. Graefes Arch Clin Exp Ophthalmol1986; 224: 26–31.
17.
ShieldsC.L., ShieldsJ.A., PerezN., SinghA.D., CaterJ.Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations. Ophthalmology2002; 109: 225–34.
ShieldsJ.A., ShieldsC.L.The management of posterior uveal melanoma. In: ShieldsJ.A., ShieldsC.L., eds. Intraocular Tumors: A Text and Atlas.Philadelphia: WB Saunders; 1992: 191–2.
21.
KarkhanehR., ChamsH., AmoliF.A.. Long-term surgical outcome of posterior choroidal melanoma treated by endoresection. Retina2007; 27: 908–14.
22.
Garcia-ArumiJ., SararolsL., MartinezV., CorcosteguiB.Vitreoretinal surgery and endoresection in high posterior melanoma. Retina2001; 21: 445–52.
23.
PeymanG.A., CohenS.B.Ab interno resection of uveal melanoma. Int Ophthalmol1986; 9: 29–36.
24.
PeymanG.A., NelsonN.C.Jr., ParisC.L., BlinderK.J., AlturkiW.A., DesaiU.R.Internal choroidectomy of posterior uveal melanomas under a retinal flap. Int Ophthalmol1992; 16: 439–44.
FouldsW.S., DamatoB.E., BurtonR.L.Local resection versus enucleation in the management of choroidal melanoma. Eye1987; 1: 676–9.
27.
ZimmermanL.E., McLeanI.W.An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol1979; 87: 741–60.
28.
The Collaborative Ocular Melanoma Study (COMS)randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10. Am J Ophthalmol1998; 125: 779–96.
29.
KeunenJ.E., Journée-De KorverJ.G., OosterhuisJ.A.Transpupillary thermotherapy of choroidal melanoma with or without brachytherapy: a dilemma. Br J Ophthalmol1999; 83: 1212–3.
30.
DamatoB.E., PaulJ., FouldsW.S.Predictive factors of visual outcome after local resection of choroidal melanoma. Br J Ophthalmol1993; 77: 616–23.
31.
BellD.J., WilsonM.W.Choroidal melanoma: natural history and management options. Cancer Control2004; 11: 296–303.
ShieldsJ.A.Overview of management of uveal melanoma. In: RyanS.J., ed. Retina. Vol. 1. 2nd ed.St Louis: CV Mosby; 1994: 762–5.
34.
ZimmermanL.E., McLeanI.W., FosterW.D.Statistical analysis of follow-up data concerning uveal melanomas, and the influence of enucleation. Ophthalmology1980; 87: 557–64.
35.
AugsburgerJ.J., GamelJ.W., LauritzenK., BradyL.W.Cobalt-60 plaque radiotherapy vs enucleation for posterior uveal melanoma. Am J Ophthalmol1990; 109: 585–92.
36.
CharC.H., CastroJ.R., QuiveyJ.M.. Uveal melanoma radiation. 1251 brachytherapy versus helium ion irradiation. Ophthalmology1989; 96: 1708–15.
37.
AugsburgerJ.J., GamelJ.W., SardiV.F., GreenbergR.A., ShieldsJ.A., BradyL.W.Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol1986; 104: 655–61.
